ArticlePharmacoEconomics2019
Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness.
Article in PharmacoEconomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Outcome measures for economic evaluations and cost-effectiveness analyses of interventions for people with intellectual disabilities: A methodological systematic review.Journal of applied research in intellectual disabilities : JARID · 2023Pooled it
- Burden of rotavirus gastroenteritis on caregivers: Findings from a systematic literature review.Human vaccines & immunotherapeutics · 2022Pooled it
- Provider and household costs ofBulletin of the World Health Organization · 2019Trial
- Measuring and valuing spillover effects in caregivers and families: A scoping review.PloS one · 2026Article
- Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessment.Journal of managed care & specialty pharmacy · 2024Article
- Modelling Informal Carers' Health-Related Quality of Life: Challenges for Economic Evaluation.Applied health economics and health policy · 2024Review
- How well do the adult social care outcomes toolkit for carers, carer experience scale and care-related quality of life capture aspects of quality of life important to informal carers in Australia?Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023Article
- Moving Forward with Taking a Societal Perspective: A Themed Issue on Productivity Costs, Consumption Costs and Informal Care Costs.PharmacoEconomics · 2023Article
- Accounting for Nonhealth and Future Costs in Cost-Effectiveness Analysis: Distributional Impacts of a US Cancer Prevention Strategy.PharmacoEconomics · 2023Article
- Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol.Cost effectiveness and resource allocation : C/E · 2023Article
- The Psychosocial Impact of Congenital Cytomegalovirus on Caregivers and Families: Lived Experiences and Review of the Literature.International journal of neonatal screening · 2023Review
- How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?BMC health services research · 2023Review
- The quality of life of older carers and the people they support: An international scoping review.Health & social care in the community · 2022Article
- The Challenges of Measuring Informal Care Time: A Review of the Literature.PharmacoEconomics · 2021Review
- The cost-effectiveness of a culturally tailored parenting program: estimating the value of multiple outcomes.Cost effectiveness and resource allocation : C/E · 2021Article
- Validation of the Hungarian version of the CarerQol instrument in informal caregivers: results from a cross-sectional survey among the general population in Hungary.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021Article
- Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy.The Journal of pediatrics · 2020Article
- Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018.PharmacoEconomics · 2020Article
- Parental health spillover effects of paediatric rare genetic conditions.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020Article
- Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?PharmacoEconomics · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
30915632What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.